Posted on Leave a comment

Happy 10th Birthday EBiSC!

We are very proud to mark 10 years of the European Bank for induced pluripotent Stem Cells distributing high-quality human induced pluripotent stem cell (iPSC) lines.

Initially established in 2014 with support from the Innovative Health Initiative and EFPIA, EBiSC distributed its first iPSC lines in 2016 and since then has shared iPSC lines to researchers all over the world.

With a catalogue of >1000 iPSC lines, covering >45 diseases as well as isogenic, familial and age-sex matched controls, EBiSC has become a trusted resource for researchers internationally, enabling access to well-characterised, quality-controlled iPSCs that underpin advances across a wealth of topics including tissue and disease modelling, organoids, genomics and feeding into drug discovery and regenerative medicine.

We’d like to share a huge thank you to our project partners, collaborators, depositors and Users whose continued engagement has been instrumental in shaping EBiSC’s success. Special thanks to Culture Collections for their previous role as the EBiSC distribution hub. We also recognise the dedication of our teams in Fraunhofer UK Research Ltd and Fraunhofer Institute for Biomedical Engineering who are responsible for operating EBiSC and whose expertise and commitment ensure the highest standards in cell banking, data management, and distribution. Thank you all!

As we look to the future, EBiSC remains committed to expanding access, enhancing quality, and supporting innovation in stem cell research. If you’d like to work with us, get in touch via Contact@EBiSC.org.

Posted on Leave a comment

Big news for biomedical researchers in Australia and New Zealand!

We’re excited to announce that CellBank Australia is now the official distributor of the EBiSC stem cell collection for Australia and New Zealand — making it easier than ever for researchers across Oceania to access 950+ high-quality iPSC lines covering more than 45 disease areas, including cardiovascular, neurological, and metabolic disorders.

This partnership expands EBiSC’s global reach, ensuring that our validated iPSC lines and pre-differentiated cells are available to support research in disease modelling, drug discovery, and regenerative medicine across the region.

Operated by the Children’s Medical Research Institute (CMRI), CellBank brings 18+ years of expertise in authenticated cell lines and quality control services. The collaboration is further strengthened by CMRI’s Stem Cell and Organoid Facility, advancing 3D organoid models and translational research.

📧 cellbank@cmri.org.au

🌐 https://www.cellbankaustralia.com/cell-lines-for-distribution/